Overview
Zurzuvae is approved by the U.S. Food and Drug Administration (FDA) to treat postpartum depression in adults. It’s prescribed for people experiencing depression after childbirth. Zurzuvae can be taken by itself…
The Zulresso brand name has been discontinued in the U.S.
Overview
Zulresso is approved by the U.S. Food and Drug Administration (FDA) for the treatment of postpartum depression (PPD) in people 15 and older. As of July…
Overview
Carbatrol is a prescription drug approved by the Food and Drug Administration (FDA) to treat trigeminal neuralgia and some types of seizures. Carbatrol is sometimes prescribed to treat certain types of… read more
The Depakene FS brand name has been discontinued in the U.S. Generic alternatives may be available.
Overview
Depakene is a prescription drug approved by the Food and Drug Administration (FDA) to treat epilepsy. Depakene is…
read more
The Eskalith brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.
Overview
Eskalith is a prescription drug approved by the Food and Drug Administration (FDA) to treat…
read moreOverview
Lamictal is a prescription drug approved by the Food and Drug Administration (FDA) to treat epilepsy and bipolar disorder. Lamictal is sometimes prescribed for people with major depressive disorder when… read more
Overview
Neurontin is a prescription drug approved by the Food and Drug Administration (FDA) to treat postherpetic neuralgia and some types of seizures. Neurontin is sometimes prescribed to treat depression and anxiety.… read more
Overview
Tegretol is a prescription drug approved by the Food and Drug Administration (FDA) to treat trigeminal neuralgia and some types of seizures. Tegretol is sometimes prescribed to treat certain types of… read more
Overview
Topamax is a prescription drug approved by the Food and Drug Administration (FDA) to treat epilepsy and migraines. Topamax is sometimes prescribed to treat depression. Since the FDA has not approved Topamax… read more